Podium to Practice: ESMO® 2025 – BREAST: POSITIVE
OR
Please enter your username or email address. You will receive an email message to log in.
Explore more from your favourite experts – click their name to access their entire library of content.
Studies / Trials Discussed
LBA12 – 5-Year Follow-up Results from the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial
Studies/trials discussed:
LBA12 – 5-Year Follow-up Results from the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial
©2025 OncologyEducation a Think Research company. All rights reserved. Privacy Policy. Privacy Notice. Accessibility Statement.
Pre-Video Survey
By continuing to watch the video, you consent to receiving a post-view survey by email.